Trial Profile
Etanercept for the Treatment of Chronic Regional Pain Syndrome
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 12 Oct 2016 Planned End Date changed from 1 Jul 2015 to 1 Oct 2016.
- 12 Oct 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Oct 2016.
- 12 Oct 2016 Status changed from recruiting to withdrawn prior to enrolment.